Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

The merits of FDDNP-PET imaging in Alzheimer's disease.

Shin J, Kepe V, Barrio JR, Small GW.

J Alzheimers Dis. 2011;26 Suppl 3:135-45. doi: 10.3233/JAD-2011-0008. Review.

PMID:
21971458
[PubMed - indexed for MEDLINE]
2.

Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.

Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.

Neuroimage. 2010 Aug 15;52(2):488-96. doi: 10.1016/j.neuroimage.2010.04.013. Epub 2010 Apr 10.

PMID:
20385246
[PubMed - indexed for MEDLINE]
3.

Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.

Barrio JR, Kepe V, Satyamurthy N, Huang SC, Small G.

J Nutr Health Aging. 2008 Jan;12(1):61S-5S.

PMID:
18165848
[PubMed - indexed for MEDLINE]
4.

PET of brain amyloid and tau in mild cognitive impairment.

Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.

N Engl J Med. 2006 Dec 21;355(25):2652-63.

PMID:
17182990
[PubMed - indexed for MEDLINE]
Free Article
5.

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

Shin J, Lee SY, Kim SH, Kim YB, Cho SJ.

Neuroimage. 2008 Nov 1;43(2):236-44. doi: 10.1016/j.neuroimage.2008.07.022. Epub 2008 Jul 23.

PMID:
18694837
[PubMed - indexed for MEDLINE]
6.

Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.

Braskie MN, Klunder AD, Hayashi KM, Protas H, Kepe V, Miller KJ, Huang SC, Barrio JR, Ercoli LM, Siddarth P, Satyamurthy N, Liu J, Toga AW, Bookheimer SY, Small GW, Thompson PM.

Neurobiol Aging. 2010 Oct;31(10):1669-78. doi: 10.1016/j.neurobiolaging.2008.09.012. Epub 2008 Nov 11.

PMID:
19004525
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.

Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, Shipley NJ, Libri V, Lockhart A.

J Neurochem. 2009 Apr;109(2):623-30. doi: 10.1111/j.1471-4159.2009.05996.x. Epub 2009 Feb 13.

PMID:
19226369
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.

Kepe V, Huang SC, Small GW, Satyamurthy N, Barrio JR.

Methods Enzymol. 2006;412:144-60. Review.

PMID:
17046657
[PubMed - indexed for MEDLINE]
9.

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile.

Agdeppa ED, Kepe V, Petri A, Satyamurthy N, Liu J, Huang SC, Small GW, Cole GM, Barrio JR.

Neuroscience. 2003;117(3):723-30.

PMID:
12617976
[PubMed - indexed for MEDLINE]
10.

Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.

Lavretsky H, Siddarth P, Kepe V, Ercoli LM, Miller KJ, Burggren AC, Bookheimer SY, Huang SC, Barrio JR, Small GW.

Am J Geriatr Psychiatry. 2009 Jun;17(6):493-502.

PMID:
19472439
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The 2,6-disubstituted naphthalene derivative FDDNP labeling reliably predicts Congo red birefringence of protein deposits in brain sections of selected human neurodegenerative diseases.

Smid LM, Vovko TD, Popovic M, Petric A, Kepe V, Barrio JR, Vidmar G, Bresjanac M.

Brain Pathol. 2006 Apr;16(2):124-30.

PMID:
16768752
[PubMed - indexed for MEDLINE]
12.

Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.

Small GW, Siddarth P, Burggren AC, Kepe V, Ercoli LM, Miller KJ, Lavretsky H, Thompson PM, Cole GM, Huang SC, Phelps ME, Bookheimer SY, Barrio JR.

Arch Gen Psychiatry. 2009 Jan;66(1):81-7. doi: 10.1001/archgenpsychiatry.2008.516.

PMID:
19124691
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.

Wardak M, Wong KP, Shao W, Dahlbom M, Kepe V, Satyamurthy N, Small GW, Barrio JR, Huang SC.

J Nucl Med. 2010 Feb;51(2):210-8. doi: 10.2967/jnumed.109.063701. Epub 2010 Jan 15.

PMID:
20080894
[PubMed - indexed for MEDLINE]
Free PMC Article
14.
15.

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.

Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR.

Am J Geriatr Psychiatry. 2002 Jan-Feb;10(1):24-35.

PMID:
11790632
[PubMed - indexed for MEDLINE]
16.

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.

Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, Cole GM, Small GW, Huang SC, Barrio JR.

J Neurosci. 2001 Dec 15;21(24):RC189.

PMID:
11734604
[PubMed - indexed for MEDLINE]
Free Article
17.

Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.

Ercoli LM, Small GW, Siddarth P, Kepe V, Huang SC, Miller KJ, Lavretsky H, Bookheimer SY, Barrio JR, Silverman DH.

Int J Geriatr Psychiatry. 2012 Oct;27(10):1017-27. doi: 10.1002/gps.2816. Epub 2012 Mar 1.

PMID:
22383132
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562
[PubMed - indexed for MEDLINE]
19.

Psychological well-being and regional brain amyloid and tau in mild cognitive impairment.

Chen ST, Siddarth P, Saito NY, Rueda F, Haight T, Ercoli LM, Miller KJ, Lavretsky H, Barrio JR, Bookheimer SY, Small GW, Merrill DA.

Am J Geriatr Psychiatry. 2014 Apr;22(4):362-9. doi: 10.1016/j.jagp.2012.09.002. Epub 2013 Mar 26.

PMID:
23567426
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

2-(1-{6-[(2-[fluorine-18]fluoroethyl)(methyl) amino]-2-naphthyl} ethylidene)malononitrile (FDDNP) positron emission tomography patterns in nondemented populations.

Shin J, Lee SY.

Am J Geriatr Psychiatry. 2010 Feb;18(2):187; author reply 188. doi: 10.1097/JGP.0b013e3181c29446. No abstract available.

PMID:
20104075
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk